Immune Thrombocytopenic Purpura following CoronaVac vaccination: a case report

Detalhes bibliográficos
Autor(a) principal: Turra Aimi, Giulia Eduarda
Data de Publicação: 2023
Outros Autores: Bosi, Guilherme Rasia, Guerra, Larissa Beatriz, Michelin, Lessandra
Tipo de documento: Artigo
Idioma: por
Título da fonte: Clinical and Biomedical Research
Texto Completo: https://seer.ufrgs.br/index.php/hcpa/article/view/121930
Resumo: Immune thrombocytopenic purpura (ITP), an autoimmune disorder, has been documented as a result of SARS-CoV-2 infection and a vaccination side effect. The COVID-19 pandemic has led to the creation of CoronaVac vaccine and has been widely administered in Brazil. Patient, in the case, is an 82-years-old female who received the vaccine two days before an acute episode of gingivorrhagia and diffuse cutaneous petechiae. Other exams were made to look for other causes of secondary thrombocytopenia and all the results were normal.  The patient showed improvement on the platelet levels three day after the beginning of the treatment with high dosage methylprednisolone.Knowing that other kinds of vaccine can generate ITP, the SARS-CoV-2 vaccine could be related to the symptoms.
id UFRGS-20_c7d7f68253cdf8727a6fb8efa5b3f761
oai_identifier_str oai:seer.ufrgs.br:article/121930
network_acronym_str UFRGS-20
network_name_str Clinical and Biomedical Research
repository_id_str
spelling Immune Thrombocytopenic Purpura following CoronaVac vaccination: a case report#covid19Immune thrombocytopenic purpura (ITP), an autoimmune disorder, has been documented as a result of SARS-CoV-2 infection and a vaccination side effect. The COVID-19 pandemic has led to the creation of CoronaVac vaccine and has been widely administered in Brazil. Patient, in the case, is an 82-years-old female who received the vaccine two days before an acute episode of gingivorrhagia and diffuse cutaneous petechiae. Other exams were made to look for other causes of secondary thrombocytopenia and all the results were normal.  The patient showed improvement on the platelet levels three day after the beginning of the treatment with high dosage methylprednisolone.Knowing that other kinds of vaccine can generate ITP, the SARS-CoV-2 vaccine could be related to the symptoms.HCPA/FAMED/UFRGS2023-03-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed ArticleAvaliado por paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/121930Clinical & Biomedical Research; Vol. 42 No. 4 (2022): Clinical and Biomedical ResearchClinical and Biomedical Research; v. 42 n. 4 (2022): Clinical and Biomedical Research2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSporhttps://seer.ufrgs.br/index.php/hcpa/article/view/121930/88091Copyright (c) 2022 Clinical and Biomedical Researchhttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessTurra Aimi, Giulia EduardaBosi, Guilherme RasiaGuerra, Larissa BeatrizMichelin, Lessandra2024-01-19T14:11:50Zoai:seer.ufrgs.br:article/121930Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2024-01-19T14:11:50Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.none.fl_str_mv Immune Thrombocytopenic Purpura following CoronaVac vaccination: a case report
title Immune Thrombocytopenic Purpura following CoronaVac vaccination: a case report
spellingShingle Immune Thrombocytopenic Purpura following CoronaVac vaccination: a case report
Turra Aimi, Giulia Eduarda
#covid19
title_short Immune Thrombocytopenic Purpura following CoronaVac vaccination: a case report
title_full Immune Thrombocytopenic Purpura following CoronaVac vaccination: a case report
title_fullStr Immune Thrombocytopenic Purpura following CoronaVac vaccination: a case report
title_full_unstemmed Immune Thrombocytopenic Purpura following CoronaVac vaccination: a case report
title_sort Immune Thrombocytopenic Purpura following CoronaVac vaccination: a case report
author Turra Aimi, Giulia Eduarda
author_facet Turra Aimi, Giulia Eduarda
Bosi, Guilherme Rasia
Guerra, Larissa Beatriz
Michelin, Lessandra
author_role author
author2 Bosi, Guilherme Rasia
Guerra, Larissa Beatriz
Michelin, Lessandra
author2_role author
author
author
dc.contributor.author.fl_str_mv Turra Aimi, Giulia Eduarda
Bosi, Guilherme Rasia
Guerra, Larissa Beatriz
Michelin, Lessandra
dc.subject.por.fl_str_mv #covid19
topic #covid19
description Immune thrombocytopenic purpura (ITP), an autoimmune disorder, has been documented as a result of SARS-CoV-2 infection and a vaccination side effect. The COVID-19 pandemic has led to the creation of CoronaVac vaccine and has been widely administered in Brazil. Patient, in the case, is an 82-years-old female who received the vaccine two days before an acute episode of gingivorrhagia and diffuse cutaneous petechiae. Other exams were made to look for other causes of secondary thrombocytopenia and all the results were normal.  The patient showed improvement on the platelet levels three day after the beginning of the treatment with high dosage methylprednisolone.Knowing that other kinds of vaccine can generate ITP, the SARS-CoV-2 vaccine could be related to the symptoms.
publishDate 2023
dc.date.none.fl_str_mv 2023-03-03
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-reviewed Article
Avaliado por pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/121930
url https://seer.ufrgs.br/index.php/hcpa/article/view/121930
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/121930/88091
dc.rights.driver.fl_str_mv Copyright (c) 2022 Clinical and Biomedical Research
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Clinical and Biomedical Research
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv HCPA/FAMED/UFRGS
publisher.none.fl_str_mv HCPA/FAMED/UFRGS
dc.source.none.fl_str_mv Clinical & Biomedical Research; Vol. 42 No. 4 (2022): Clinical and Biomedical Research
Clinical and Biomedical Research; v. 42 n. 4 (2022): Clinical and Biomedical Research
2357-9730
reponame:Clinical and Biomedical Research
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Clinical and Biomedical Research
collection Clinical and Biomedical Research
repository.name.fl_str_mv Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv ||cbr@hcpa.edu.br
_version_ 1799767056350969856

Registros relacionados